Jiang He
Auto-generated profile, based on publicly available information

Jiang He

University of Texas Southwestern Medical Center

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
KMKatherine T. Mills
Katherine T. Mills
ASAndrei Stefanescu
Andrei Stefanescu
JHJiang He
Jiang He

9 August 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
KMKatherine T. Mills
Katherine T. Mills
JBJoshua D. Bundy
Joshua D. Bundy
TKTanika N. Kelly
Tanika N. Kelly
JRJennifer E. Reed
Jennifer E. Reed
PKPatricia M. Kearney
Patricia M. Kearney
JHJiang He
Jiang He
Background: Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010. Methods: We searched MEDLINE from 1995 through 2014 and supplemented with manual searches of retrieved article references. We included 135 population-based studies of 968 419 adults from 90 countries. Sex- and age-specific hypertension prevalences from each country were applied to population data to calculate regional and global numbers of hypertensive adults. Proportions of awareness, treatment, and control from each country were applied to hypertensive populations to obtain regional and global estimates. Results: In 2010, 31.1% (95% confidence interval, 30.0%–32.2%) of the world’s adults had hypertension; 28.5% (27.3%–29.7%) in high-income countries and 31.5% (30.2%–32.9%) in low- and middle-income countries. An estimated 1.39 (1.34–1.44) billion people had hypertension in 2010: 349 (337–361) million in high-income countries and 1.04 (0.99–1.09) billion in low- and middle-income countries. From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-income countries, but increased by 7.7% in low- and middle-income countries. During the same period, the proportions of awareness (58.2% versus 67.0%), treatment (44.5% versus 55.6%), and control (17.9% versus 28.4%) increased substantially in high-income countries, whereas awareness (32.3% versus 37.9%) and treatment (24.9% versus 29.0%) increased less, and control (8.4% versus 7.7%) even slightly decreased in low- and middle-income countries. Conclusions: Global hypertension disparities are large and increasing. Collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.

15 January 2005 in The Lancet
Verified
Journal Article
Closed access
PDF file
PKPatricia M Kearney
Patricia M Kearney
MWMegan Whelton
Megan Whelton
KRKristi Reynolds
Kristi Reynolds
PMPaul Muntner
Paul Muntner
PWPaul K Whelton
Paul K Whelton
JHJiang He
Jiang He

1 April 2018 in The Lancet
Verified
Journal Article
Closed access
CWChen Wang
Chen Wang
JXJianying Xu
Jianying Xu
LYLan Yang
Lan Yang
YXYongjian Xu
Yongjian Xu
XZXiangyan Zhang
Xiangyan Zhang
JHJiang He
Jiang He

2 April 2002 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
SWSeamus P. Whelton
Seamus P. Whelton
ACAshley Chin
Ashley Chin
XXXue Xin
Xue Xin
JHJiang He
Jiang He
Physical activity has been associated with reduced blood pressure in observational epidemiologic studies and individual clinical trials. This meta-analysis of randomized, controlled trials was conducted to determine the effect of aerobic exercise on blood pressure. English-language articles published before September 2001. 54 randomized, controlled trials (2419 participants) whose intervention and control groups differed only in aerobic exercise. Using a standardized protocol and data extraction form, three of the investigators independently abstracted data on study design, sample size, participant characteristics, type of intervention, follow-up duration, and treatment outcomes. In a random-effects model, data from each trial were pooled and weighted by the inverse of the total variance. Aerobic exercise was associated with a significant reduction in mean systolic and diastolic blood pressure (-3.84 mm Hg [95% CI, -4.97 to -2.72 mm Hg] and -2.58 mm Hg [CI, -3.35 to -1.81 mm Hg], respectively). A reduction in blood pressure was associated with aerobic exercise in hypertensive participants and normotensive participants and in overweight participants and normal-weight participants. Aerobic exercise reduces blood pressure in both hypertensive and normotensive persons. An increase in aerobic physical activity should be considered an important component of lifestyle modification for prevention and treatment of high blood pressure.

3 February 2004 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
JCJing Chen
Jing Chen
PMPaul Muntner
Paul Muntner
LHL. Lee Hamm
L. Lee Hamm
DJDaniel W. Jones
Daniel W. Jones
VBVecihi Batuman
Vecihi Batuman
JHJiang He
Jiang He
The metabolic syndrome is a common risk factor for cardiovascular disease. To examine the association between the metabolic syndrome and risk for chronic kidney disease and microalbuminuria. Cross-sectional study. The Third National Health and Nutrition Examination Survey. Participants 20 years of age or older were studied in the chronic kidney disease (n = 6217) and microalbuminuria (n = 6125) analyses. The metabolic syndrome was defined as the presence of 3 or more of the following risk factors: elevated blood pressure, low high-density lipoprotein cholesterol level, high triglyceride level, elevated glucose level, and abdominal obesity. Chronic kidney disease was defined as a glomerular filtration rate less than 60 mL/min per 1.73 m2, and microalbuminuria was defined as a urinary albumin–creatinine ratio of 30 to 300 mg/g. The multivariate-adjusted odds ratios of chronic kidney disease and microalbuminuria in participants with the metabolic syndrome compared with participants without the metabolic syndrome were 2.60 (95% CI, 1.68 to 4.03) and 1.89 (CI, 1.34 to 2.67), respectively. Compared with participants with 0 or 1 component of the metabolic syndrome, participants with 2, 3, 4, and 5 components of chronic kidney disease had multivariate-adjusted odds ratios of 2.21 (CI, 1.16 to 4.24), 3.38 (CI, 1.48 to 7.69), 4.23 (CI, 2.06 to 8.63), and 5.85 (CI, 3.11 to 11.0), respectively. The corresponding multivariate-adjusted odds ratios of microalbuminuria for participants with 3, 4, and 5 components were 1.62 (CI, 1.10 to 2.38), 2.45 (CI, 1.55 to 3.85), and 3.19 (CI, 1.96 to 5.19), respectively. These findings suggest that the metabolic syndrome might be an important factor in the cause of chronic kidney disease.